Baird Medical Investment Holdings (BDMD) Receivables (2023 - 2026)

Baird Medical Investment Holdings (BDMD) has reported Receivables for 4 consecutive years, with $30.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables fell 31.66% year-over-year to $30.7 million in Q2 2026; TTM through Jun 2026 was $30.7 million, a 31.66% decrease from a year earlier, with the FY2025 full-year figure at $47.3 million, down 7.14% from the prior year.
• Receivables was $30.7 million for Q2 2026 at Baird Medical Investment Holdings, down from $42.5 million in the prior quarter.
• Over five years, Receivables peaked at $50.9 million in Q4 2024 and troughed at $30.7 million in Q2 2026.
• A 4-year average of $40.7 million and a median of $42.5 million in 2025 frame the typical range for Receivables.
• Across the five-year window, Receivables jumped 48.36% in 2024 and slumped 31.66% in 2026, its largest moves.
• Over 4 years, Receivables stood at $34.3 million in 2023, then jumped by 48.36% to $50.9 million in 2024, then slipped by 16.51% to $42.5 million in 2025, then retreated by 27.86% to $30.7 million in 2026.
• The last three Receivables figures came in at $30.7 million (Q2 2026), $42.5 million (Q4 2025), and $44.9 million (Q2 2025), per Business Quant data.